Digest Network Come funziona
Network
/
Società
Se
Non verificato

Seaport Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

18 comunicati stampa

Guarda tutti i comunicati
04/12/2025
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Eventi
Web e Social Network
Seaport Therapeutics to Present at 2025 RBC Capital Markets Healthcare Private Company Conference
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
04/11/2025
Eventi
Web e Social Network
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Seaport Therapeutics to Present at Stifel 2025 Healthcare Conference
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
18/09/2025
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Seaport Therapeutics to Participate in Upcoming Investor Conferences
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
11/09/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
Industria
Seaport Therapeutics Advances Second Therapeutic Candidate into Clinical Development with Dosing of First Participant in Phase 1 Study of GlyphAgo™ (SPT-320) in Healthy Volunteers
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
17/07/2025
Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
24/04/2025
Eventi
Industria
Biotecnologia
Psichiatria
Salute
Farmaceutica
Medicina - Varie
Seaport Therapeutics Presents New Preclinical Data on SPT-320 (Glyph Agomelatine) at the Society of Biological Psychiatry (SOBP) Annual Meeting
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
31/03/2025
Web e Social Network
Eventi
Biotecnologia
Psichiatria
Salute
Farmaceutica
Seaport Therapeutics to Participate in Upcoming Investor Conferences in April
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
11/03/2025
Mercato del lavoro
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
03/03/2025
Biotecnologia
Psichiatria
Salute
Farmaceutica
Web e Social Network
Eventi
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0
21/02/2025
Eventi
Industria
Biotecnologia
Psichiatria
Salute
Farmaceutica
Medicina - Varie
Seaport Therapeutics Presents New Meta-Analysis Examining Correlations Between Clinical Trial Design Factors and Placebo Response in Major Depressive Disorder Studies
Fonte
Seaport Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0